Cesar Bonilla Isaza, MD
Cardiovascular Disease · Apopka, FLNPI 1598088668
Payments from drug & device makers
Across 204 payments — averaging $525.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$52K
- Biosense Webster, Inc.$43K
- Biotronik Inc.$5K
- Abbott$3K
- Boston Scientific$1K
- Medtronic$1K
- plus $2K from 11 others
What the payments were for
- Consulting fees$80,23675%
- Speaking & faculty fees$9001%
- Travel & lodging$18,67317%
- Food & beverage$7,3507%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 20 | $52,249 |
| Biosense Webster, Inc. | 53 | $42,936 |
| Biotronik Inc. | 31 | $4,907 |
| Abbott | 34 | $2,969 |
| Boston Scientific | 7 | $1,180 |
| Medtronic(2 entities) | 16 | $1,098 |
| Kestra Medical Technology Services, Inc. | 9 | $471 |
| Cvrx, Inc. | 11 | $432 |
| Elutia, Inc. | 5 | $341 |
| Cardiva Medical, Inc. | 2 | $211 |
| Atricure, Inc. | 8 | $184 |
| Baxter Healthcare | 3 | $53 |
| Cordis US CORP. | 1 | $33 |
| Vital Connect, Inc | 1 | $32 |
| Stereotaxis Inc | 1 | $24 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $21 |
| Merck | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$88,828
- AMPLATZER AMULET$1,947
- GENERAL - THERAPIES$967
- BioMonitor$399
- Claria MRI$262
- Assure WCD$247
- Barostim Neo System$240
- ENSITE PRECISION$178
- ECM Patch,Pouch$178
- Cardiva VASCADE MVP VVCS 6-12F$178
- Arctic Front$137
- AVEIR$132
- Solia$129
- Rivacor$129
- Edora$129
- Acticor$129
- LINQ II$101
How this compares
$107,160 in reported general payments places this provider in the 85th percentile of 1,740 cardiovascular disease providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 183 | $175,430 |
| XareltoRivaroxaban | 75 | $78,193 |
| EntrestoSacubitril/Valsartan | 18 | $18,714 |
| Flecainide Acetate | 37 | $2,735 |
| Amiodarone Hcl | 68 | $838 |
| Metoprolol Succinate | 51 | $826 |
| SotalolSotalol Hcl | 14 | $370 |
| Carvedilol | 40 | $364 |
| Atorvastatin Calcium | 25 | $349 |
| ClopidogrelClopidogrel Bisulfate | 18 | $335 |
| Spironolactone | 17 | $280 |
| Metoprolol Tartrate | 33 | $261 |
| Amlodipine Besylate | 41 | $250 |
| Lisinopril | 17 | $200 |
| Losartan Potassium | 35 | $133 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Apopka
- Michael KorenGainesville$31M
- Seth BaumBoca Raton$11.1M
- Alexis GutierrezHialeah$8M
- Eric SpivackAventura$7.1M
- William OneillNaples$4.6M
- Rafik AbadierInverness$4.4M
- Alvaro MurciaPembroke Pines$4M
- David HotchkissPort Charlotte$4M
- Ferris GeorgeSt Augustine$3.8M
- Duccio BaldariWellington$3.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.